# Fifth District Bancorp, Inc.: overview FDSB · Nasdaq · CIK 2012726 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fdsb.md) · [Financials](/companies/fdsb/financials.md) · [Filings](/companies/fdsb/filings.md) · [Insiders](/companies/fdsb/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.15)](/filings/0001104659-25-109288.md) | not reported | [0.02](/filings/0001104659-26-059501.md) | [0.61](/filings/0001104659-26-093464.md) | [0.07](/filings/0001104659-25-109288.md) | not reported | [0.08](/filings/0001104659-26-059501.md) | [0.08](/filings/0001104659-26-093464.md) | | Free cash flow | $k | [710 d](/filings/0001104659-25-109288.md) | [(659) d](/filings/0001104659-26-033945.md) | [765](/filings/0001104659-26-059501.md) | [249 d](/filings/0001104659-26-093464.md) | [54.0 d](/filings/0001104659-25-109288.md) | [(126) d](/filings/0001104659-26-033945.md) | [736](/filings/0001104659-26-059501.md) | [596 d](/filings/0001104659-26-093464.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | | Revenue | $k | [614](/filings/0001558370-25-003713.md) | [619](/filings/0001104659-26-033945.md) | [605](/filings/0001104659-26-033945.md) | | Gross margin | % | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | | Net margin | % | [129.8%](/filings/0001558370-25-003713.md) | [(174.2%)](/filings/0001104659-26-033945.md) | [675.7%](/filings/0001104659-26-033945.md) | | Diluted EPS | $ per share | not reported | [(0.21)](/filings/0001104659-26-033945.md) | [0.80](/filings/0001104659-26-033945.md) | | Free cash flow | $k | [(1,112)](/filings/0001558370-25-003713.md) | [(1,564)](/filings/0001104659-26-033945.md) | [942](/filings/0001104659-26-033945.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fdsb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $5.3m | 356,440 | | Added +44,317 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.7m | 226,320 | | Reduced −6,928 | | [MANGROVE PARTNERS IM, LLC](/funds/1535392.md) | 2026-06-30 | $2.3m | 141,766 | | Unchanged | | [STILWELL VALUE LLC](/funds/1397076.md) | 2026-06-30 | $1.3m | 80,000 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.0m | 62,600 | | Reduced −1,356 | | [Daytona Street Capital LLC](/funds/2101936.md) | 2026-06-30 | $868.8k | 50,000 | | New +50,000 | | [Waverly Advisors, LLC](/funds/1568787.md) | 2026-06-30 | $856.0k | 52,741 | | New +52,741 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $813.2k | 50,102 | | Added +102 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $792.6k | 48,810 | | Reduced −1,347 | | [Arcus Capital Partners, LLC](/funds/1651960.md) | 2026-06-30 | $597.3k | 36,804 | | Added +300 | ## Recent filings [All 80 filings](/companies/fdsb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-10 | 17:16 ET | [10-Q](/filings/0001104659-26-093464.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093464 | | 2026-06-09 | 17:15 ET | [8-K](/filings/0001104659-26-071915.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-071915 | | 2026-05-20 | 17:15 ET | [8-K](/filings/0001104659-26-064612.md) | 5.07 Shareholder vote results | 0001104659-26-064612 | | 2026-05-12 | 17:15 ET | [10-Q](/filings/0001104659-26-059501.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059501 | | 2026-04-13 | 17:00 ET | [DEF 14A](/filings/0001104659-26-042677.md) | Proxy statement, period 2026-05-18 | 0001104659-26-042677 | | 2026-03-24 | 17:16 ET | [10-K](/filings/0001104659-26-033945.md) | Annual report, period 2025-12-31 | 0001104659-26-033945 | | 2026-02-09 | 17:07 ET | [8-K](/filings/0000943374-26-000070.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000943374-26-000070 | | 2025-11-10 | 17:16 ET | [10-Q](/filings/0001104659-25-109288.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109288 | | 2025-09-16 | 16:12 ET | [8-K](/filings/0000943374-25-000401.md) | 5.07 Shareholder vote results | 0000943374-25-000401 | | 2025-08-25 | 16:16 ET | [8-K](/filings/0001558370-25-011755.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011755 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-033945.md), filed Mar 24, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 2012726 - Tickers: FDSB - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.